A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
Silvio Caccia, Roberto William Invernizzi, Alessandro Nobili, Luca Pasina IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy Abstract: Cariprazine is a potential antipsychotic awaiting approval from the US Food and Drug Administration. It is a dopamine D2- and D3-receptor partial ag...
Saved in:
Main Authors: | Caccia S (Author), Invernizzi RW (Author), Nobili A (Author), Pasina L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010) -
Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)
by: Nakamura T, et al.
Published: (2016) -
Cariprazine: An Antipsychotic Medication with High Therapeutic Potential
by: Wiktoria, et al.
Published: (2024) -
New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine
by: Werner FM, et al.
Published: (2015) -
Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review
by: Marcin Siwek, et al.
Published: (2024)